midazolam has been researched along with d-alpha tocopherol in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Burnett, JR; Clarke, MW; Croft, KD; Hodgson, JM; Ledowski, T; Puddey, IB; Wu, JH | 1 |
Bai, P; Chang, H; Chen, J; Feng, Y | 1 |
1 review(s) available for midazolam and d-alpha tocopherol
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for midazolam and d-alpha tocopherol
Article | Year |
---|---|
Vitamin E supplementation and hepatic drug metabolism in humans.
Topics: Adult; alpha-Tocopherol; Area Under Curve; Biotransformation; Chromans; Cytochrome P-450 CYP3A; Dietary Supplements; Double-Blind Method; Drug Interactions; Female; gamma-Tocopherol; Humans; Liver; Male; Midazolam; Middle Aged; Pharmaceutical Preparations; Propionates; Vitamin E | 2009 |
2 other study(ies) available for midazolam and d-alpha tocopherol
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Diffuse posterior leukoencephalopathy in MELAS without stroke-like episodes: A case report.
Topics: Acidosis, Lactic; Ascorbic Acid; Female; Humans; Leukoencephalopathies; Levetiracetam; Male; MELAS Syndrome; Midazolam; Middle Aged; Stroke; Vitamin E; Vitamins | 2023 |